Total Payments
$16,812
2024 Payments
$1,969
Companies
88
Transactions
1,054
Medicare Patients
3,509
Medicare Billing
$237,423
Payment Breakdown by Category
Food & Beverage$16,453 (97.9%)
Education$358.38 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,453 | 1,047 | 97.9% |
| Education | $358.38 | 7 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,966 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,646 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,418 | 79 | $0 (2024) |
| Novo Nordisk Inc | $1,340 | 98 | $0 (2024) |
| Lilly USA, LLC | $947.12 | 67 | $0 (2024) |
| PFIZER INC. | $841.42 | 95 | $0 (2024) |
| GlaxoSmithKline, LLC. | $811.13 | 58 | $0 (2024) |
| Astellas Pharma US Inc | $701.17 | 25 | $0 (2024) |
| Allergan, Inc. | $664.23 | 43 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $455.52 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,969 | 122 | ABBVIE INC. ($501.83) |
| 2023 | $2,358 | 145 | ABBVIE INC. ($424.58) |
| 2022 | $2,261 | 128 | ABBVIE INC. ($503.53) |
| 2021 | $2,203 | 125 | AbbVie Inc. ($400.52) |
| 2020 | $1,975 | 116 | AstraZeneca Pharmaceuticals LP ($521.70) |
| 2019 | $1,992 | 129 | AstraZeneca Pharmaceuticals LP ($258.39) |
| 2018 | $1,732 | 133 | Novo Nordisk Inc ($181.14) |
| 2017 | $2,322 | 156 | Boehringer Ingelheim Pharmaceuticals, Inc. ($421.21) |
All Payment Transactions
1,054 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Obesity | ||||||
| 10/08/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 791 | 1,047 | $185,592 | $49,858 |
| 2022 | 15 | 838 | 1,084 | $187,810 | $51,753 |
| 2021 | 21 | 1,118 | 1,435 | $206,222 | $82,190 |
| 2020 | 18 | 762 | 1,059 | $134,530 | $53,622 |
Total Patients
3,509
Total Services
4,625
Medicare Billing
$237,423
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 274 | $71,788 | $14,094 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 172 | 284 | $52,540 | $12,328 | 23.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $9,220 | $5,926 | 64.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 101 | 101 | $26,967 | $4,969 | 18.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 66 | 68 | $6,120 | $4,878 | 79.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 74 | $2,960 | $2,297 | 77.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,420 | $1,575 | 35.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 75 | 75 | $2,850 | $1,412 | 49.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $789.80 | $682.88 | 86.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $5,115 | $629.61 | 12.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $585.00 | $415.44 | 71.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $780.00 | $277.70 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $700.00 | $221.54 | 31.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 32 | 41 | $738.00 | $132.99 | 18.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $19.38 | $19.00 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 257 | $67,334 | $13,501 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 301 | $55,685 | $13,256 | 23.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 88 | 89 | $7,950 | $6,018 | 75.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $23,496 | $4,974 | 21.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $5,708 | $3,337 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 91 | 92 | $3,665 | $2,753 | 75.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,705 | $1,990 | 29.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 102 | 102 | $3,876 | $1,944 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,420 | $1,242 | 28.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $5,580 | $1,049 | 18.8% |
About Dr. Suzanne Nash, MD
Dr. Suzanne Nash, MD is a Family Medicine healthcare provider based in Thornton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336146273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Nash, MD has received a total of $16,812 in payments from pharmaceutical and medical device companies, with $1,969 received in 2024. These payments were reported across 1,054 transactions from 88 companies. The most common payment nature is "Food and Beverage" ($16,453).
As a Medicare-enrolled provider, Nash has provided services to 3,509 Medicare beneficiaries, totaling 4,625 services with total Medicare billing of $237,423. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Thornton, CO
- Active Since 07/07/2005
- Last Updated 05/02/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336146273
Products in Payments
- VRAYLAR (Drug) $1,194
- JARDIANCE (Drug) $983.65
- FARXIGA (Drug) $796.12
- UBRELVY (Drug) $453.38
- Ozempic (Drug) $444.72
- TRELEGY ELLIPTA (Drug) $440.53
- NURTEC ODT (Drug) $356.29
- SYMBICORT (Drug) $345.97
- XARELTO (Drug) $338.69
- MOUNJARO (Drug) $319.54
- CHANTIX (Drug) $307.84
- Prolastin-C Liquid (Biological) $304.66
- Saxenda (Drug) $255.25
- Trintellix (Drug) $234.80
- TRULICITY (Drug) $231.86
- EMGALITY (Drug) $208.15
- AUSTEDO (Drug) $204.60
- LINZESS (Drug) $203.95
- MYRBETRIQ (Drug) $195.95
- JANUVIA (Drug) $183.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Thornton
Dr. Kenneth Hahn, Do, DO
Family Medicine — Payments: $21,946
Family Medicine $21,946
Dr. Philip Rosenblum, Md, MD
Family Medicine — Payments: $19,181
Family Medicine $19,181
Kent Schreiber, Md, MD
Family Medicine — Payments: $18,397
Family Medicine $18,397
James Weingart, Md, MD
Family Medicine — Payments: $13,329
Family Medicine $13,329
Ann Imhof, Md, MD
Family Medicine — Payments: $12,668
Family Medicine $12,668
Nancy Stoudt, Md, MD
Family Medicine — Payments: $10,008
Family Medicine $10,008